Ultram and Haemangioma of skin - a phase IV clinical study of FDA data

Summary:

Haemangioma of skin is reported only by a few people who take Ultram.

The phase IV clinical study analyzes which people take Ultram and have Haemangioma of skin. It is created by eHealthMe based on reports of 25,693 people who have side effects while taking Ultram from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jun, 10, 2023

25,693 people reported to have side effects when taking Ultram.
Among them, 1 person (0.0%) has Haemangioma of skin.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 27,263 Ultram users for its effectiveness, alternative drugs and more.

What is Haemangioma of skin?

Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs) is found to be associated with 538 drugs and 280 conditions by eHealthMe.

Number of Ultram and Haemangioma of skin reports submitted per year:

Time on Ultram when people have Haemangioma of skin *:

Gender of people who have Haemangioma of skin when taking Ultram *:

female: 100 %
male: 0.0 %

Age of people who have Haemangioma of skin when taking Ultram *:

Common drugs people take besides Ultram *:

Common side effects people have besides Haemangioma of skin *:

Uterine Haemorrhage (uterine bleeding): 1 person, 100.00%
Migraine (headache): 1 person, 100.00%
Lymphocyte Count Decreased: 1 person, 100.00%
Heavy Or Prolong Menstrual Bleeding: 1 person, 100.00%
Fatigue (feeling of tiredness): 1 person, 100.00%
Dysmenorrhea (painful menstruation): 1 person, 100.00%
Device Dislocation: 1 person, 100.00%
Abdominal Pain: 1 person, 100.00%
Abdominal Distension: 1 person, 100.00%

Common conditions people have *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 100.00%
Migraine Without Aura (headache without neurological problems): 1 person, 100.00%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 100.00%
Depression: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram and have Haemangioma of skin?

Check whether Haemangioma of skin is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

Related studies

How severe was Haemangioma of skin and when was it recovered:

Haemangioma of skin in Ultram

Expand to all the drugs that have ingredients of tramadol hydrochloride:

Haemangioma of skin and drugs with ingredients of tramadol hydrochloride (6 reports)

Alternative drugs to, pros and cons of Ultram:

Ultram (27,263 reports)

Common Ultram side effects:

Pain: 2,373 reports
Fatigue (feeling of tiredness): 2,096 reports
Weakness: 1,701 reports
Headache (pain in head): 1,674 reports
Drug ineffective: 1,603 reports
Breathing difficulty: 1,588 reports

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Haemangioma of skin treatments and more:

Haemangioma of skin (542 reports)

COVID vaccines that are related to Haemangioma of skin:

Common drugs associated with Haemangioma of skin:

Gilenya: 174 reports

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram) and Ultram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.